Breaking News
FDA Approves Biocon Biologics’ Yesafili™, Interchangeable Biosimilar Eylea

Biocon Biologics today announced that the U.S. Food and Drug Administration (US FDA) has approved th...

read more
FDA Approves Biocon Biologics’ Yesafili™, Interchangeable Biosimilar Eylea
May 21, 2024
FDA Approves Glenmark’s Ophthalmic Solution for Glaucoma, Bioequivalent to Abbvie's Combigan

Glenmark Pharmaceuticals has received final approval by the FDA for Brimonidine Tartrate and Timolol...

read more
FDA Approves Glenmark’s Ophthalmic Solution for Glaucoma, Bioequivalent to Abbvie's Combigan
May 17, 2024
Scientists Develop Eye-Tracking Smart Contact Lenses with Radio Frequency Tags

Scientists from Nanjing, China, have developed a novel eye-tracking smart contact lenses based on ra...

read more
Scientists Develop Eye-Tracking Smart Contact Lenses with Radio Frequency Tags
May 16, 2024
Breakthrough Smart Contact Lens Measures Eye Pressure in All Temperatures

Researchers have developed a prototype "smart" contact lens that accurately measures eye pressure re...

read more
Breakthrough Smart Contact Lens Measures Eye Pressure in All Temperatures
May 10, 2024
Living Contact Lens Uses Lubricant-Producing Bacteria to Combat Dry Eye

Researchers have developed a new type of contact lens that contains a community of lubricant-produci...

read more
Living Contact Lens Uses Lubricant-Producing Bacteria to Combat Dry Eye
May 09, 2024
Innovative 3D Retinal Electrodes Developed to Restore Vision in Blind Patients

A groundbreaking study led by Professor Sohee Kim from the Department of Robotics and Mechatronics E...

read more
Innovative 3D Retinal Electrodes Developed to Restore Vision in Blind Patients
May 09, 2024
Alcon to Acquire Belkin Vision for Up to $325 Million

Alcon has enhanced its offerings in glaucoma surgery by announcing its acquisition of Belkin Vision,...

read more
Alcon to Acquire Belkin Vision for Up to $325 Million
May 08, 2024
Novel Gene Therapy Improves Vision in Children with Leber Congenital Amaurosis

In a landmark clinical trial, CRISPR-Cas9 gene editing has proven safe and effective in treating a f...

read more
Novel Gene Therapy Improves Vision in Children with Leber Congenital Amaurosis
May 07, 2024
FDA Greenlights AEYE Health's Autonomous AI for Portable Diabetic Retinopathy Screening

AEYE Health received FDA clearance for its fully autonomous AI, making it the first to diagnose refe...

read more
FDA Greenlights AEYE Health's Autonomous AI for Portable Diabetic Retinopathy Screening
May 02, 2024
Alcon Hit with $34M Penalty for Patent Infringement Against Sight Sciences

Sight Sciences has received a positive jury trial verdict of $34 million associated with the patent ...

read more
Alcon Hit with $34M Penalty for Patent Infringement Against Sight Sciences
April 30, 2024
More